Cargando…

Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study

OBJECTIVES: The aim of this study was to investigate the association of serum fibrinogen with cardiovascular events (CVE) in Chinese patients with type 2 diabetes mellitus (T2DM) and stable coronary artery disease (CAD). DESIGN: An observational study. SETTING: FuWai Hospital in Beijing, China. PART...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sheng-Hua, Du, Ying, Zhang, Yan, Li, Xiao-Lin, Li, Sha, Xu, Rui-Xia, Zhu, Cheng-Gang, Guo, Yuan-Lin, Wu, Na-Qiong, Qing, Ping, Gao, Ying, Cui, Chuan-Jue, Dong, Qian, Sun, Jing, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734258/
https://www.ncbi.nlm.nih.gov/pubmed/28601829
http://dx.doi.org/10.1136/bmjopen-2016-015041
_version_ 1783287028011499520
author Yang, Sheng-Hua
Du, Ying
Zhang, Yan
Li, Xiao-Lin
Li, Sha
Xu, Rui-Xia
Zhu, Cheng-Gang
Guo, Yuan-Lin
Wu, Na-Qiong
Qing, Ping
Gao, Ying
Cui, Chuan-Jue
Dong, Qian
Sun, Jing
Li, Jian-Jun
author_facet Yang, Sheng-Hua
Du, Ying
Zhang, Yan
Li, Xiao-Lin
Li, Sha
Xu, Rui-Xia
Zhu, Cheng-Gang
Guo, Yuan-Lin
Wu, Na-Qiong
Qing, Ping
Gao, Ying
Cui, Chuan-Jue
Dong, Qian
Sun, Jing
Li, Jian-Jun
author_sort Yang, Sheng-Hua
collection PubMed
description OBJECTIVES: The aim of this study was to investigate the association of serum fibrinogen with cardiovascular events (CVE) in Chinese patients with type 2 diabetes mellitus (T2DM) and stable coronary artery disease (CAD). DESIGN: An observational study. SETTING: FuWai Hospital in Beijing, China. PARTICIPANTS: A cohort of 1466 patients with T2DM and angiographic-proven stable CAD was evaluated. OUTCOME MEASURES: Baseline serum fibrinogen levels were measured and trisected into ‘low’, ‘middle’ and ‘high’. Their association with CVE was explored using Cox proportional hazard models. RESULTS: With 20.2 months (average) follow-up, 44 (3%) were lost to follow-up and 96 patients developed CVE. Compared with the patients without CVE, the ones who developed CVE had higher levels of fibrinogen. Univariable regression revealed a significant relation of fibrinogen to CVE (HR (HR) 1.25, 95% CI 1.06 to 1.47, p=0.010) per SD increase of fibrinogen at baseline. After adjusting for multiple established cardiovascular disease (CVD) risk factors, the association persisted (HR 1.30, 95% CI 1.02 to 1.66, p=0.037). Moreover, after adjusting for CVD risk factors, the HRs for middle-serum and high-serum fibrinogen concentration, using ‘low’ group as reference, were 1.23 (95% CI 0.69 to 2.20) and 2.20 (95% CI 1.11 to 3.36, p=0.049). CONCLUSIONS: We first indicated that elevated fibrinogen level was independently associated with increased CVE in Chinese patients with T2DMand stable CAD.
format Online
Article
Text
id pubmed-5734258
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57342582017-12-20 Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study Yang, Sheng-Hua Du, Ying Zhang, Yan Li, Xiao-Lin Li, Sha Xu, Rui-Xia Zhu, Cheng-Gang Guo, Yuan-Lin Wu, Na-Qiong Qing, Ping Gao, Ying Cui, Chuan-Jue Dong, Qian Sun, Jing Li, Jian-Jun BMJ Open Cardiovascular Medicine OBJECTIVES: The aim of this study was to investigate the association of serum fibrinogen with cardiovascular events (CVE) in Chinese patients with type 2 diabetes mellitus (T2DM) and stable coronary artery disease (CAD). DESIGN: An observational study. SETTING: FuWai Hospital in Beijing, China. PARTICIPANTS: A cohort of 1466 patients with T2DM and angiographic-proven stable CAD was evaluated. OUTCOME MEASURES: Baseline serum fibrinogen levels were measured and trisected into ‘low’, ‘middle’ and ‘high’. Their association with CVE was explored using Cox proportional hazard models. RESULTS: With 20.2 months (average) follow-up, 44 (3%) were lost to follow-up and 96 patients developed CVE. Compared with the patients without CVE, the ones who developed CVE had higher levels of fibrinogen. Univariable regression revealed a significant relation of fibrinogen to CVE (HR (HR) 1.25, 95% CI 1.06 to 1.47, p=0.010) per SD increase of fibrinogen at baseline. After adjusting for multiple established cardiovascular disease (CVD) risk factors, the association persisted (HR 1.30, 95% CI 1.02 to 1.66, p=0.037). Moreover, after adjusting for CVD risk factors, the HRs for middle-serum and high-serum fibrinogen concentration, using ‘low’ group as reference, were 1.23 (95% CI 0.69 to 2.20) and 2.20 (95% CI 1.11 to 3.36, p=0.049). CONCLUSIONS: We first indicated that elevated fibrinogen level was independently associated with increased CVE in Chinese patients with T2DMand stable CAD. BMJ Publishing Group 2017-06-09 /pmc/articles/PMC5734258/ /pubmed/28601829 http://dx.doi.org/10.1136/bmjopen-2016-015041 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Cardiovascular Medicine
Yang, Sheng-Hua
Du, Ying
Zhang, Yan
Li, Xiao-Lin
Li, Sha
Xu, Rui-Xia
Zhu, Cheng-Gang
Guo, Yuan-Lin
Wu, Na-Qiong
Qing, Ping
Gao, Ying
Cui, Chuan-Jue
Dong, Qian
Sun, Jing
Li, Jian-Jun
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
title Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
title_full Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
title_fullStr Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
title_full_unstemmed Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
title_short Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
title_sort serum fibrinogen and cardiovascular events in chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734258/
https://www.ncbi.nlm.nih.gov/pubmed/28601829
http://dx.doi.org/10.1136/bmjopen-2016-015041
work_keys_str_mv AT yangshenghua serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT duying serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT zhangyan serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT lixiaolin serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT lisha serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT xuruixia serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT zhuchenggang serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT guoyuanlin serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT wunaqiong serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT qingping serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT gaoying serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT cuichuanjue serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT dongqian serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT sunjing serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy
AT lijianjun serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy